BioMarker Strategies
Culmination Bio, Cofactor Genomics Team up on Study to Advance Immunotherapy Response Test
Culmination will give Cofactor access to over 4.5 million biological samples to advance the firm's assay to predict immunotherapy response in 11 cancer types.
BioMarker Strategies Wins NCI Grant to Develop Head and Neck Cancer CDx
The company is developing a companion diagnostic to identify head and neck cancer patients most likely to benefit from Erbitux.
The company has received grant funding for diagnostic development projects, and is also seeking its first pharma service customers to provide nearer-term revenue.
BioMarker Strategies Lands $2.3M in NCI SBIR Grants
The funding will go towards developing the PathMap companion diagnostic technology, based on the firm's SnapPath platform.
People in the News: Jerry Parrott, Jonathan Drachman, Eric Sievers, Christoph Franz, Franz Humer
Premium
BioMarker Strategies has appointed Jerry Parrott as its new president, CEO, and director, effective immediately.
Oct 5, 2012
Oct 3, 2012
Jun 1, 2011
Pairings: Jun 1, 2011
Premium
Jan 12, 2011
Pairings: Jan 12, 2011
Premium
Jan 7, 2011
Movers & Shakers: Jan 7, 2011
Premium
Oct 7, 2009
NCI Grants BioMarker Strategies SBIR Funds
May 1, 2009